Who owns PHARMACYTE BIOTECH INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Pharmacyte Biotech with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pharmacyte Biotech stock

Who bought or sold PHARMACYTE BIOTECH INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
K2 Principal Fund 209k $400k -36% Sep 2024
 View chart
Vanguard Group 192k $377k 10% Jun 2024
 View chart
Geode Capital Management 168k $321k -5% Sep 2024
 View chart
Equitec Proprietary Markets 83k $158k 0% Sep 2024
 View chart
Renaissance Technologies 50k $95k 2% Sep 2024
 View chart
Susquehanna International 35k $67k -36% Sep 2024
 View chart
Two Sigma Securities 28k $54k 100% Jun 2024
 View chart
Dimensional Fund Advisors 28k $53k 8% Sep 2024
 View chart
Schonfeld Strategic Advisors 26k $50k 9% Sep 2024
 View chart
Northern Trust 19k $37k 0% Sep 2024
 View chart
BlackRock 13k $26k -37% Jun 2024
 View chart
Tower Research Capital 7.4k $15k 129% Jun 2024
 View chart
Acadian Asset Management 2.9k $5.0k 0% Sep 2024
 View chart
Aspire Private Capital 800.00 $1.5k 0% Sep 2024
 View chart
Advisor Group Holdings 508.00 $968.298800 -71% Sep 2024
 View chart
Covestor 226.00 $0 0% Sep 2024
 View chart
Bank of America Corporation 117.00 $222.861600 -23% Sep 2024
 View chart
Royal Bank of Canada 100.00 $0 -62% Sep 2024
 View chart
Planning Capital Management Corp 100.00 $191.000000 0% Sep 2024
 View chart
Maryland Capital Advisors 35.00 $68.001500 100% Sep 2024
 View chart
Jpmorgan Chase & Co 18.00 $34.000200 -5% Sep 2024
 View chart
Sachetta 14.00 $28.000000 0% Sep 2024
 View chart
BFSG 5.00 $10.000000 0% Sep 2024
 View chart
Morgan Stanley 3.00 $6.999900 0% Jun 2024
 View chart
Jones Financial Companies, L.L 2.00 $4.000000 100% Sep 2024
 View chart
Goss Wealth Management 2.00 $4.000000 -33% Jun 2024
 View chart
CWM 1.00 $0 0% Sep 2024
 View chart

Who sold out of Pharmacyte Biotech?

Fund or Company Name Date Sold Shares Held Valued At
Kelly Financial Services Jun 2024 234.00 $458.991000
Redwood Wealth Management Group Jun 2024 69.00 $134.998500
Private Wealth Management Group Mar 2024 42.00 $100.002000